Opioid regulation of the mouse δ-opioid receptor expressed in human embryonic kidney 293 cells

Molecular Pharmacology

Volumn 52, Issue 2, 1997, Pages 272-281

  Bot, George ^a   Blake, Allan D ^a   Li, Shuixing ^a   Reisine, Terry ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ANALGESIC AGENT; CYCLIC AMP; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; EPITOPE; ETHYLKETAZOCINE; ETORPHINE; FORSKOLIN; LEUCINE ENKEPHALIN[2 DEXTRO SERINE 6 THREONINE]; LEVORPHANOL; METHADONE; MORPHINE; MU OPIATE RECEPTOR; OPIATE; OXYMORPHONE;

ARTICLE; BINDING AFFINITY; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG TOLERANCE; EMBRYO; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTERNALIZATION; MORPHINE ADDICTION; MORPHINE TOLERANCE; PAIN; POINT MUTATION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION;

EID: 0030872198     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.2.272     Document Type: Article

References (40)

1. Serturner, F. W. A. Darstellung der reinen Mohnasaure (Opiumsaure): nebst einer chemischen Untersuchung des opiums, mit vorzuglicher Hinsicht auf einen darin neu entdeckten stoff. J. Pharm. Arzte. Apoth. Chem. 14:47-93 (1805).
2. Reisine, T., and G. Pasternak. Opioid analgesics and antagonists, in The Pharmacological Basis of Therapeutics (J. G. Hardman, L. E. Limbard, P. B. Molinoff, R. W. Ruddon, and A. G. Gilman, eds). McGraw-Hill, New York, 521-555 (1993).
3. Raynor, K., H. Kong, Y. Chen, K. Yasuda, L. Yu, G. I. Bell, and T. Reisine. Pharmacological characterization of the cloned κ-, δ-, and μ-opioid receptors. Mol. Pharmacol. 45:330-334 (1994).
4. Rapaka, R. S., and F. Porreca. Development of delta opioid peptides as nonaddicting analgesics. Pharmaceut. Res. 8:1-8 (1991).
5. Heyman, J. S., J. L. Vaught, R. B. Raffa, and F. Porreca. Can supraspinal delta-opioid receptors mediate antinociception? Trends Pharmacol. Sci. 9:134-138 (1988).
6. Cowan, A., X. Z. Zhu, H. I. Mosberg, J. R. Omnaas, and F. Porreca. Direct dependence studies in rats with agents selective for different types of opioid receptor. J. Pharmacol. Exp. Ther. 246:950-955 (1988).
7. Maldonado, R., S. Negus, and G. F. Koob. Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Neuropharmacology 31:1231-1241 (1992).
8. Abdelhamid, E. E., M. Sultana, P. S. Portoghese, and A. E. Takemori. Selective blockade of delta opioid receptor prevents the development of morphine tolerance and dependence in mice. J. Pharmacol. Exp. Ther. 258:299-303 (1991).
9. Fundytus, M. E., P. W. Schiller, M. Shapiro, G. Weltrowska, and T. Coderre. Attenuation of morphine tolerance and dependence with the highly selective delta-opioid receptor antagonist TIPP(ψ). Eur. J. Pharmacol. 286:105-108 (1995).
10. Nestler, E. J. Under siege: the brain opiate. Neuron 16:897-900 (1996).
11. Law, P. Y., D. S. Hom, and H. H. Loh. Opiate regulation of adenosine 3′:5′-cyclic monophosphate level in neuroblastoma X glioma NG108-15 hybrid cells. Mol. Pharmacol. 23:26-35 (1983).
12. Cai, Y., Y. Zhang, Y. Wu, and G. Pei. δ-Opioid receptor in neuronal cells undergoes acute and homologous desensitization. Biochem. Biophys. Res. Commun. 219:342-347 (1996).
13. Pei, G., B. L. Kieffer, R. J. Lefkowitz, and N. J. Freedman. Agonist-dependent phosphorylation of the mouse δ-opioid receptor: involvement of G protein-coupled receptor kinases but not protein kinase C. Mol. Pharmacol. 48:173-177 (1995).
14. Zadina, J. E., L. M. Harrison, L.-J. Ge, A. J. Kastin, and S. L. Chang. Differential regulation of mu and delta opiate receptors by morphine, selective agonists and antagonists and differentiating agents in SH-SY5Y human neuroblastima cells. J. Pharmacol. Exp. Ther. 270:1086-1096 (1994).
15. von Zastrow, M., D. Keith, P. Zaki, and C. Evans. Intracellular trafficking of epitope-tagged opioid receptors: different effects of morphine and enkephalin. Reg. Peptides, 54:315-316 (1994).
16. Keith, D., S. R. Murray, P. Zaki, P. C. Chu, D. Lissin, L. Kang, C. J. Evans, and M. von Zastrow. Morphine activates opioid receptors without causing their rapid internalization. J. Biol. Chem. 271:19021-19024 (1996).
17. Chen, C. A., and H. Okayama. Calcium phosphate-mediate gene transfer: a high efficient transfection system for stable transforming cells with plasmid DNA. Biotechniques 6:632-638 (1988).
18. Blake, A. D., G. Bot, X. Li, J. Freeman, and T. Reisine. Differential opioid agonist regulation of the mouse μ opioid receptor. J. Biol. Chem. 272:782-790 (1997).
19. Blake, A. D., G. Bot., X. Li., J. Freeman, and T. Reisine. Differential agonist regulation of the human κ opioid receptor. J. Neurochem. 68:1846-1852 (1997).
20. Wang, W. W., M. Shahrestanifar, J. Jin, and R. D. Howells. Studies on μ, and δ opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc. Natl. Acad. Sci. USA 92:12436-12440 (1995).
21. Befort, K., L. Tabbara, S. Bausch, C. Chavkin, C. Evans, and B. Kieffer. The conserved aspartate residue in the third putative transmembrane domain of the δ-opioid receptor is not the anionic counterpart for the cationic opiate binding but is a constituent of the receptor binding site. Mol. Pharmacol. 49:216-223 (1996).
22. Meng, F., Y. Ueda, M. T. Hoversten, R. C. Thompson, R. Taylor, S. J. Watson, and H. Akil. Mapping the receptor domains critical for the binding selectivity of δ-opioid receptor ligands. Eur. J. Pharmacol. 311:285-292 (1996).
23. Valiquette, M., H. K. Vu, S. Y. Yue, C. Wahlestedt, P. Walker. Involvement of Trp-284, Val-296 and Val-297 of the human δ-opioid receptor in binding of the δ-selective ligands. J. Biol. Chem. 271:18789-18796 (1996).
24. Arden, J. R., V. Segredo, Z. Wang, J. Lameh, and W. Sadee. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor in HEK 293 cells. J. Neurochem. 65:1636-1645 (1995).
25. Tsu, R. C., J. S. C. Chan, and Y. H. Wong. Regulation of multiple effectors by the cloned delta-opioid receptor: stimulation of phospholipase C and type II adenylyl cyclase. J. Neurochem. 64:2700-2707 (1995).
26. Blake, A. D., von Zastrow, M., and Reisine, T. Agonist induced regulation of mu and delta opioid receptors. Soc. Neurosci. 21:1350 (1995).
27. 1 opioid receptor agonists and antagonists. J. Med. Chem. 36:2572-2574 (1993).
28. Bergsbaken, C. L., S. L. Sommers, and P. Y. Law. Effect of forskolin and isobutylmethylxanthine on delta opioid receptor activity in neuroblastoma X glioma NG108-15 cells. J. Pharmacol. Exp. Ther. 264:1474-1482 (1993).
29. Law, P. Y., T. M. McGinn, M. J. Wick, L. J. Erickson, C. Evans, and H. H. Loh. Analysis of delta receptor activities stably expressed in CHO cell lines: function of receptor density? J. Pharmacol. Exp. Ther. 271:1686-1694 (1994).
30. Malatynska, E., Y. Wang, R. J. Knapp, S. Waite, S. Calderon, K. Rice, V. J. Hruby, H. I. Yamamura, and W. R. Roeske. Human delta opioid receptor: functional studies on stably transfected Chinese hamster ovary cells after acute and chronic treatment with the selective nonpeptidic agonist SNC-80. J. Pharmacol. Exp. Ther. 278:1083-1089 (1996).
31. Katsumata, S., M. Minami, T. Nakagawa, T. Iwamura, and M. Satoh. Pharmacological study of dihydroetorphine in cloned μ-, δ- and κ-opioid receptors. Eur. J. Pharmacol. 291:367-373 (1996).
32. Evans, C. J., D. E. Jr. Keith, H. Morrison, K. Magendzo, and R. H. Edwards. Cloning of a delta opioid receptor by functional expression. Science (Washington D.C.) 258:1952-1955 (1992).
33. Fukuda, K., S. Kato, and K. Mori. Location of regions of the opioid receptor involved in selective agonist binding. J. Biol. Chem. 270:6702-6709 (1995).
34. Kieffer, B. L., K. Befort, C. Gaveriaux-Ruff, and C. G. Hirth. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 89:12048-12052 (1992).
35. Law, S. F., and T. Reisine. Changes in the association of G protein subunits with the cloned mouse delta opioid receptor upon agonist stimulation. J. Pharmacol. Exp. Ther. 281:1476-1486 (1997).
36. Paronis, C. A., and S. G. Holtzman. Development of tolerance to the analgesic activity of μ-agonists after continuous infusion of morphine, meperidine or fentanyl in rats. J. Pharmacol. Exp. Ther. 262:1-9 (1992).
37. Crews, J. C., N. J. Sweeney, and D. D. Denson. Clinical efficacy of methadone in patients refractory to other μ-opioid receptor agonist analgesics for management of terminal cancer pain. Cancer 72:2266-2272 (1993).
38. Takemori, A. E., and P. S. Portoghese. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in β-funaltrexamine-treated mice. J. Pharmacol. Exp. Ther. 243:91-94 (1987).
39. 2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine. Life Sci. 56:45-50 (1995).
40. Self, D. W., and E. J. Nestler. Molecular machanism of drug reinforcement and addiction. Annu. Rev. Neurosci. 18:463-495 (1995).